24 results on '"Kvols L"'
Search Results
2. Octreotide use in patients with metastatic pancreatic neuroendocrine tumors.
3. Risk of metastatic spread in patients with early-stage, surgically resected pancreatic neuroendocrine tumors.
4. Incidental diagnosis of pancreatic neuroendocrine tumors.
5. Stage I nonfunctioning neuroendocrine tumors of the pancreas: Surgery or surveillance?
6. Phase II study of sunitinib malate following hepatic artery embolization for metastatic neuroendocrine tumors.
7. Prognostic relevance of a novel AJCC staging classification for neuroendocrine tumors of the pancreas.
8. Role of immunohistochemistry in the diagnosis of poorly differentiated neuroendocrine carcinoma.
9. Adoption of neuroendocrine tumor (NET) research into treatment guidelines: Are rare cancers neglected?
10. Primary gastroenteropancreatic poorly differentiated neuroendocrine carcinoma: Clinico-pathologic analysis of 68 cases
11. First-line treatment of metastatic pancreatic endocrine carcinomas with capecitabine and temozolomide
12. Novel progression-associated genes in pancreatic endocrine neoplasms
13. Phase II proof-of-concept study of atiprimod in patients with advanced low- to intermediate-grade neuroendocrine carcinoma
14. Clinicopathologic analysis of well, moderately and poorly differentiated gastroenteropancreatic neuroendocrine tumors
15. The effects of pasireotide (SOM230) on health-related quality of life in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR
16. Safety and efficacy of pasireotide (SOM230) in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR: Results of a phase II study
17. Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR
18. Peptide receptor radiotherapy (PRRT) with [Y-90-DOTA,Tyr3]octreotide: Toxicity and efficacy of 4-cycle and single-cycle regimens
19. Phase I trial of carboplatin, irinotecan and etoposide in advanced solid tumors
20. Phase I trial of carboplatin, irinotecan and etoposide in advanced solid tumors
21. Peptide receptor radiotherapy (PRRT) with [Y-90-DOTA,Tyr3]octreotide: Toxicity and efficacy of 4-cycle and single-cycle regimens
22. Carcinoid syndrome.
23. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.
24. Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.